RS54844B1 - Injektabilni superzasićeni rastvor acetaminofena za spinalnu primenu - Google Patents

Injektabilni superzasićeni rastvor acetaminofena za spinalnu primenu

Info

Publication number
RS54844B1
RS54844B1 RS20160435A RSP20160435A RS54844B1 RS 54844 B1 RS54844 B1 RS 54844B1 RS 20160435 A RS20160435 A RS 20160435A RS P20160435 A RSP20160435 A RS P20160435A RS 54844 B1 RS54844 B1 RS 54844B1
Authority
RS
Serbia
Prior art keywords
acetaminophen
supersaturated
solution
aqueous solution
local anesthetic
Prior art date
Application number
RS20160435A
Other languages
English (en)
Serbian (sr)
Inventor
Augusto Mitidieri
Elisabetta Donati
Nicola Caronzolo
Original Assignee
Sintetica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46690603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS54844(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sintetica S A filed Critical Sintetica S A
Publication of RS54844B1 publication Critical patent/RS54844B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0085Brain, e.g. brain implants; Spinal cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20160435A 2012-06-29 2013-06-27 Injektabilni superzasićeni rastvor acetaminofena za spinalnu primenu RS54844B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001154A ITMI20121154A1 (it) 2012-06-29 2012-06-29 Soluzione iniettabile di acetaminofene per la somministrazione spinale
PCT/IB2013/055277 WO2014002042A1 (en) 2012-06-29 2013-06-27 Injectable supersaturated acetaminophen solution for spinal administration
EP13765450.5A EP2874602B1 (en) 2012-06-29 2013-06-27 Injectable supersaturated acetaminophen solution for spinal administration

Publications (1)

Publication Number Publication Date
RS54844B1 true RS54844B1 (sr) 2016-10-31

Family

ID=46690603

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20160435A RS54844B1 (sr) 2012-06-29 2013-06-27 Injektabilni superzasićeni rastvor acetaminofena za spinalnu primenu

Country Status (44)

Country Link
US (2) US11344517B2 (enExample)
EP (1) EP2874602B1 (enExample)
JP (1) JP5876620B2 (enExample)
KR (1) KR102118227B1 (enExample)
CN (1) CN104487051B (enExample)
AP (1) AP2014008152A0 (enExample)
AR (1) AR091633A1 (enExample)
AU (1) AU2013282753B2 (enExample)
BR (1) BR112014032818B1 (enExample)
CA (1) CA2876801C (enExample)
CL (1) CL2014003536A1 (enExample)
CO (1) CO7240357A2 (enExample)
CR (1) CR20150036A (enExample)
CU (1) CU20140150A7 (enExample)
CY (1) CY1117691T1 (enExample)
DK (1) DK2874602T3 (enExample)
DO (1) DOP2014000302A (enExample)
EA (1) EA028909B1 (enExample)
EC (1) ECSP15000500A (enExample)
ES (1) ES2578012T3 (enExample)
GE (1) GEP201706689B (enExample)
HR (1) HRP20160706T1 (enExample)
HU (1) HUE029431T2 (enExample)
IL (1) IL236423A (enExample)
IT (1) ITMI20121154A1 (enExample)
MA (1) MA37811B1 (enExample)
MD (1) MD4537C1 (enExample)
ME (1) ME02431B (enExample)
MX (1) MX369264B (enExample)
MY (1) MY169251A (enExample)
NI (1) NI201400147A (enExample)
NZ (1) NZ703829A (enExample)
PE (1) PE20150331A1 (enExample)
PH (1) PH12015500178B1 (enExample)
PL (1) PL2874602T3 (enExample)
PT (1) PT2874602T (enExample)
RS (1) RS54844B1 (enExample)
SG (2) SG11201408479WA (enExample)
SI (1) SI2874602T1 (enExample)
SM (1) SMT201600248B (enExample)
TN (1) TN2014000526A1 (enExample)
UA (1) UA117101C2 (enExample)
WO (1) WO2014002042A1 (enExample)
ZA (1) ZA201409478B (enExample)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0162115B1 (ko) * 1993-04-14 1998-11-16 노자키 지로 용존산소 감소장치
US6171298B1 (en) * 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
WO2003051398A1 (en) * 2001-12-18 2003-06-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenteral composition of paracetamol
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) * 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
AU2006346318B2 (en) * 2006-07-18 2011-02-10 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
CN101015542A (zh) * 2007-02-13 2007-08-15 天津生机集团有限公司 家畜用复方对乙酰氨基酚注射液及其制备方法
MD3528G2 (ro) * 2007-09-28 2008-11-30 Сергей ШАНДРУ Metodă de anestezie spinală continuă la pacienţii în etate
CA2705733C (en) * 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
WO2009098716A2 (en) 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
WO2009143558A1 (en) * 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
JP2013006770A (ja) * 2009-10-09 2013-01-10 Ssp Co Ltd アセトアミノフェン含有経口液剤
PH12012502444A1 (en) * 2010-06-30 2013-02-11 Troikaa Pharmaceuticals Ltd Pharmaceutical compositions comprising paracetamol and process for preparing the same

Also Published As

Publication number Publication date
PE20150331A1 (es) 2015-03-07
PT2874602T (pt) 2016-07-13
MA37811B1 (fr) 2017-07-31
MX2014015402A (es) 2015-06-17
CU20140150A7 (es) 2015-10-27
ITMI20121154A1 (it) 2013-12-30
ES2578012T3 (es) 2016-07-20
AP2014008152A0 (en) 2014-12-31
MD4537C1 (ro) 2018-07-31
NI201400147A (es) 2015-04-13
US20150148379A1 (en) 2015-05-28
US11344517B2 (en) 2022-05-31
EP2874602B1 (en) 2016-03-30
JP5876620B2 (ja) 2016-03-02
CN104487051B (zh) 2017-12-12
DOP2014000302A (es) 2015-03-15
HUE029431T2 (en) 2017-03-28
DK2874602T3 (en) 2016-07-04
PL2874602T3 (pl) 2016-10-31
SI2874602T1 (sl) 2016-09-30
CN104487051A (zh) 2015-04-01
KR20150027160A (ko) 2015-03-11
MX369264B (es) 2019-11-04
ME02431B (me) 2016-09-20
SMT201600248B (it) 2016-08-31
CL2014003536A1 (es) 2015-05-08
AU2013282753A1 (en) 2015-02-05
SG11201408479WA (en) 2015-01-29
NZ703829A (en) 2016-06-24
MA37811A1 (fr) 2016-10-31
EP2874602A1 (en) 2015-05-27
AR091633A1 (es) 2015-02-18
CA2876801C (en) 2020-11-03
CY1117691T1 (el) 2017-05-17
ECSP15000500A (es) 2015-11-30
IL236423A (en) 2017-07-31
MD4537B1 (ro) 2017-12-31
TN2014000526A1 (en) 2016-03-30
BR112014032818A2 (pt) 2017-06-27
JP2015522004A (ja) 2015-08-03
GEP201706689B (en) 2017-06-26
CR20150036A (es) 2015-03-13
BR112014032818B1 (pt) 2022-06-14
CA2876801A1 (en) 2014-01-03
EA028909B1 (ru) 2018-01-31
ZA201409478B (en) 2016-01-27
IL236423A0 (en) 2015-02-26
EA201500065A1 (ru) 2015-10-30
US20160128955A1 (en) 2016-05-12
UA117101C2 (uk) 2018-06-25
WO2014002042A1 (en) 2014-01-03
CO7240357A2 (es) 2015-04-17
MD20140138A2 (ro) 2015-06-30
SG10201704482YA (en) 2017-07-28
KR102118227B1 (ko) 2020-06-03
HRP20160706T1 (hr) 2016-08-12
AU2013282753B2 (en) 2017-03-02
PH12015500178A1 (en) 2015-04-06
MY169251A (en) 2019-03-19
PH12015500178B1 (en) 2021-08-04

Similar Documents

Publication Publication Date Title
Sunshine New clinical experience with tramadol
JPH064534B2 (ja) 長期間の疼痛緩和をもたらす配合剤
Ali et al. Articaine vs lidocaine: a review
AU2013282753B2 (en) Injectable supersaturated acetaminophen solution for spinal administration
US11672863B2 (en) Enhanced solubility drug-containing formulations
US9504666B2 (en) Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
US20100190860A1 (en) Methods for selectively enhancing antinociceptive potency of local anesthetics
OA17190A (en) Injectable supersaturated acetaminophen solution for spinal administration.
Farquhar-Smith The additive analgesia of adrenaline in epidural blockade
WO2025212904A1 (en) Pharmaceutical oil-in-water emulsion for treating pain
Khandelwal et al. Intrathecal Hyperbaric Ropivacaine for Day Case Pelvic, Perineal and Lower Limb Surgeries–A Prospective Study
Wright et al. Pain CHAPTER and analgesia
Jagan et al. Frontiers in Medical Case Reports
Ghazi et al. Acute pain in peripheral vascular disease
WO2013067612A1 (pt) Composição farmacêutica para preparação de um medicamento para tratar dores neuropáticas, dores associadas às doenças degenerativas crónicas e em pós-operatórios dolorosos de animais